MFS
SNDX icon

Mirabella Financial Services’s Syndax Pharmaceuticals SNDX Stock Holding History

Mirabella Financial Services’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,574
Closed -$171K – 473
2020
Q3 		$171K Buy
+11,574
New +$176K 0.02% 295

Other funds holding SNDX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirabella Financial Services's SNDX Position: Q4 2020 in Review

Mirabella Financial Services sold out of Syndax Pharmaceuticals (SNDX) in Q4 2020, closing a stake of 11,574 shares — an estimated $171K sold.

Mirabella Financial Services first reported a position in SNDX in Q3 2020 and held it in 1 quarter. The position peaked at $171K in Q3 2020. 142 funds tracked by Wall St. Rank hold SNDX as of Q4 2020.

  • Mirabella Financial Services reported no remaining Syndax Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Mirabella Financial Services sold 11,574 Syndax Pharmaceuticals shares in Q4 2020, an estimated $171K.
  • Mirabella Financial Services first reported a position in Syndax Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • Mirabella Financial Services's Syndax Pharmaceuticals position peaked at $171K in Q3 2020.
  • 142 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q4 2020.

Based on Mirabella Financial Services's 13F filing for Q4 2020, filed 16 Feb 2021.